Cargando…

Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor

The recent outbreak of COVID-19 caused by SARS-CoV-2 brought a great global public health and economic concern. SARS-CoV-2 is an enveloped RNA virus, from the genus Betacoronavirus. Although few molecules have been tested and shown some efficacy against SARS-CoV-2 in humans but a safe and cost-effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Maurya, Vimal K., Kumar, Swatantra, Prasad, Anil K., Bhatt, Madan L. B., Saxena, Shailendra K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245990/
https://www.ncbi.nlm.nih.gov/pubmed/32656311
http://dx.doi.org/10.1007/s13337-020-00598-8
_version_ 1783537860704468992
author Maurya, Vimal K.
Kumar, Swatantra
Prasad, Anil K.
Bhatt, Madan L. B.
Saxena, Shailendra K.
author_facet Maurya, Vimal K.
Kumar, Swatantra
Prasad, Anil K.
Bhatt, Madan L. B.
Saxena, Shailendra K.
author_sort Maurya, Vimal K.
collection PubMed
description The recent outbreak of COVID-19 caused by SARS-CoV-2 brought a great global public health and economic concern. SARS-CoV-2 is an enveloped RNA virus, from the genus Betacoronavirus. Although few molecules have been tested and shown some efficacy against SARS-CoV-2 in humans but a safe and cost-effective attachment inhibitors are still required for the treatment of COVID-19. Natural products are gaining attention because of the large therapeutic window and potent antiviral, immunomodulatory, anti-inflammatory, and antioxidant properties. Therefore, this study was planned to screen natural products from Ayurveda that have the potential to modulate host immune system as well as block the virus entry in host cells by interfering its interaction with cellular receptor and may be used to develop an effective and broad-spectrum strategy for the management of COVID-19 as well as other coronavirus infections in coming future. To decipher the antiviral activity of the selected natural products, molecular docking was performed. Further, the drug-likeness, pharmacokinetics and toxicity parameters of the selected natural products were determined. Docking results suggest that curcumin and nimbin exhibits highest interaction with spike glycoprotein (MolDock score − 141.36 and − 148.621 kcal/mole) and ACE2 receptor (MolDock score − 142.647 and − 140.108 kcal/mole) as compared with other selected natural products/drugs and controls. Also, the pharmacokinetics data illustrated that all selected natural products have better pharmacological properties (low molecular weight; no violation of Lipinski rule of five, good absorption profiles, oral bioavailability, good blood–brain barrier penetration, and low toxicity risk). Our study exhibited that curcumin, nimbin, withaferin A, piperine, mangiferin, thebaine, berberine, and andrographolide have significant binding affinity towards spike glycoprotein of SARS-CoV-2 and ACE2 receptor and may be useful as a therapeutic and/or prophylactic agent for restricting viral attachment to the host cells. However, few other natural products like resveratrol, quercetin, luteolin, naringenin, zingiberene, and gallic acid has the significant binding affinity towards ACE2 receptor only and therefore may be used for ACE2-mediated attachment inhibition of SARS-CoV-2.
format Online
Article
Text
id pubmed-7245990
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer India
record_format MEDLINE/PubMed
spelling pubmed-72459902020-05-26 Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor Maurya, Vimal K. Kumar, Swatantra Prasad, Anil K. Bhatt, Madan L. B. Saxena, Shailendra K. Virusdisease Original Article The recent outbreak of COVID-19 caused by SARS-CoV-2 brought a great global public health and economic concern. SARS-CoV-2 is an enveloped RNA virus, from the genus Betacoronavirus. Although few molecules have been tested and shown some efficacy against SARS-CoV-2 in humans but a safe and cost-effective attachment inhibitors are still required for the treatment of COVID-19. Natural products are gaining attention because of the large therapeutic window and potent antiviral, immunomodulatory, anti-inflammatory, and antioxidant properties. Therefore, this study was planned to screen natural products from Ayurveda that have the potential to modulate host immune system as well as block the virus entry in host cells by interfering its interaction with cellular receptor and may be used to develop an effective and broad-spectrum strategy for the management of COVID-19 as well as other coronavirus infections in coming future. To decipher the antiviral activity of the selected natural products, molecular docking was performed. Further, the drug-likeness, pharmacokinetics and toxicity parameters of the selected natural products were determined. Docking results suggest that curcumin and nimbin exhibits highest interaction with spike glycoprotein (MolDock score − 141.36 and − 148.621 kcal/mole) and ACE2 receptor (MolDock score − 142.647 and − 140.108 kcal/mole) as compared with other selected natural products/drugs and controls. Also, the pharmacokinetics data illustrated that all selected natural products have better pharmacological properties (low molecular weight; no violation of Lipinski rule of five, good absorption profiles, oral bioavailability, good blood–brain barrier penetration, and low toxicity risk). Our study exhibited that curcumin, nimbin, withaferin A, piperine, mangiferin, thebaine, berberine, and andrographolide have significant binding affinity towards spike glycoprotein of SARS-CoV-2 and ACE2 receptor and may be useful as a therapeutic and/or prophylactic agent for restricting viral attachment to the host cells. However, few other natural products like resveratrol, quercetin, luteolin, naringenin, zingiberene, and gallic acid has the significant binding affinity towards ACE2 receptor only and therefore may be used for ACE2-mediated attachment inhibition of SARS-CoV-2. Springer India 2020-05-24 2020-06 /pmc/articles/PMC7245990/ /pubmed/32656311 http://dx.doi.org/10.1007/s13337-020-00598-8 Text en © Indian Virological Society 2020
spellingShingle Original Article
Maurya, Vimal K.
Kumar, Swatantra
Prasad, Anil K.
Bhatt, Madan L. B.
Saxena, Shailendra K.
Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor
title Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor
title_full Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor
title_fullStr Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor
title_full_unstemmed Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor
title_short Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor
title_sort structure-based drug designing for potential antiviral activity of selected natural products from ayurveda against sars-cov-2 spike glycoprotein and its cellular receptor
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245990/
https://www.ncbi.nlm.nih.gov/pubmed/32656311
http://dx.doi.org/10.1007/s13337-020-00598-8
work_keys_str_mv AT mauryavimalk structurebaseddrugdesigningforpotentialantiviralactivityofselectednaturalproductsfromayurvedaagainstsarscov2spikeglycoproteinanditscellularreceptor
AT kumarswatantra structurebaseddrugdesigningforpotentialantiviralactivityofselectednaturalproductsfromayurvedaagainstsarscov2spikeglycoproteinanditscellularreceptor
AT prasadanilk structurebaseddrugdesigningforpotentialantiviralactivityofselectednaturalproductsfromayurvedaagainstsarscov2spikeglycoproteinanditscellularreceptor
AT bhattmadanlb structurebaseddrugdesigningforpotentialantiviralactivityofselectednaturalproductsfromayurvedaagainstsarscov2spikeglycoproteinanditscellularreceptor
AT saxenashailendrak structurebaseddrugdesigningforpotentialantiviralactivityofselectednaturalproductsfromayurvedaagainstsarscov2spikeglycoproteinanditscellularreceptor